Promoting Open Access to Exploring the Research

The treatment of WHO Category 1 tuberculosis with 2HRZE/6HE is indeed defensible

Mathew, R and Santha, T (2000) The treatment of WHO Category 1 tuberculosis with 2HRZE/6HE is indeed defensible. International Journal of Tuberculosis and Lung Disease, 4 (9). p. 795. ISSN Print: 1027-3719; Online: 1815-7920

[img] PDF
200004.pdf - Published Version
Restricted to Registered users only

Download (13kB) | Request a copy
Official URL: http://docstore.ingenta.com/cgi-bin/ds_deliver/1/u...

Abstract

THIS IS in response to the position taken by Drs Richard Long and Marcella Scalcini in their counterpoint published in this Journal that the regimen 2HRZE/6HE: 1) has not been studied in a randomised controlled trial, 2) is ‘non-curative’ in the presence of initial isoniazid-resistance, and 3) will lead to non-adherence and failure of the regimen if allowed to be self-administered by patients

NIRT Creators:
NIRT CreatorsEmail
Item Type: Article
Subjects: Tuberculosis > Clinical Research
Divisions: Clinical Research
Depositing User: Dr. Rathinasabapati R
Date Deposited: 05 Nov 2013 10:38
Last Modified: 10 Mar 2016 08:26
URI: http://eprints.nirt.res.in/id/eprint/514

Actions (login required)

View Item View Item